Drug data last refreshed 2h ago · AI intelligence enriched 1mo ago
IPLEX is a subcutaneous small-molecule injectable approved by BLA in December 2005 for treatment of coagulation disorders, acute major bleeding, and perioperative bleeding, with additional labeled indications spanning surgical procedures (knee arthroplasty, hepatectomy, liver transplant), infectious diseases (CMV, HIV, community-acquired pneumonia), and inflammatory conditions (vitiligo, autoimmune disease, allergic rhinitis). The mechanism of action and pharmacologic class are not disclosed in available data. The product is sponsored by Insmed and currently approaching loss of exclusivity.
Product is in late-stage lifecycle with moderate competitive pressure (30/100); team size likely stabilizing as exclusivity window narrows.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)
Differential Target Multiplexed Spinal Cord Stimulation (DTM-SCS®) Real World Outcomes
Confirmatory Clinical Study of Oxiplex
Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.
A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer
Worked on IPLEX at Insmed? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on IPLEX offers exposure to complex multi-indication commercialization and regulatory strategy within a mature franchise; roles emphasize cost management, market access, and operational efficiency rather than launch dynamics. The approaching LOE environment favors professionals skilled in generic transition planning, payer negotiations, and organizational restructuring.
90 open roles linked to this drug